Nurix Therapeutics, Inc. NRIX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s preferred stock, shares authorized?
- Nurix Therapeutics, Inc. (NRIX) reported preferred stock, shares authorized of $10M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s preferred stock, shares authorized changed year-over-year?
- Nurix Therapeutics, Inc.'s preferred stock, shares authorized decreased by 0.0% year-over-year, from $10M to $10M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s preferred stock, shares authorized?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.